Health and Family Planning Commission publishes MES diagnosis and treatment plan and infection prevention and control guide

Source: China News Network June 3, 2015 according to the figures released by the World Health Organization, as of May 31, 2015, through experimental detection, there were 1150 confirmed cases of Middle East respiratory syndrome (mers) infection in the world, including at least 427 deaths related to mers It is understood that at present, more than 97% of cases occur in the Middle East, and more than 20 countries have reported cases, all of which are epidemiological related to the Middle East No primary infection cases have been found outside the Middle East According to the technical guidelines for the prevention and control of nosocomial infection, according to the statistics of 402 cases of mers infection in Saudi Arabia, 27% of medical staff were infected, 57.8% of them were asymptomatic or mild This shows that mers virus has limited human to human transmission ability, but there is no evidence that the virus has sustained human to human transmission ability The incubation period of Middle East respiratory syndrome is 2-14 days, with acute respiratory infection as the main manifestation The onset of the disease is acute, and the body temperature is as high as 39-40 ℃ It can be accompanied by chills, coughs, headaches, aching muscles and joints, anorexia and other symptoms In some cases, atypical clinical manifestations such as diarrhea were the first symptoms According to the diagnosis and treatment plan, the treatment of Middle East respiratory syndrome is mainly symptomatic support treatment, and there is no clear and effective antiviral treatment   According to the guidelines for prevention and control of nosocomial infection, the monitoring and control measures adopted by the Chinese government include: active treatment of patients, strengthening measures for control of nosocomial infection; detection of patients' specimens, sequencing of viruses and ensuring the biological safety of laboratories; strengthening emergency monitoring, especially the screening of fever in outpatients; strengthening the tracking, management and health monitoring of close contacts; Ensure risks are communicated to the public.